Fingerprint
Dive into the research topics of 'Phase I/II trial of granisetron: A novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically